FDA grants accelerated approval to Ultragenyx gene therapy for GSDIa

August 19, 2026 5:21 PM

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that the U.S. Food and Drug Administration granted accelerated approval for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found